Session Details
[P01]Poster 1 (4. Host Defense and Immunity / Odd Number)
Wed. Sep 18, 2024 11:40 AM - 12:40 PM JST
Wed. Sep 18, 2024 2:40 AM - 3:40 AM UTC
Wed. Sep 18, 2024 2:40 AM - 3:40 AM UTC
Lecture Hall(3F, Foyer)
[P083]Modulation Effect of IL-27 on Serum Levels of IL-10 and IL-2 in Mice Infected with Plasmodium berghei
○Maxwell Salvador Surya Atmaja1, Heny Arwati1 (1. Universitas Airlangga (Indonesia))
[S05-6 (P085)]Evolving humoral immune response to SARS-CoV-2 antigenic shift from XBB to JN.1 lineages
○Fanchong Jian1,2, Jing Wang1,2, Ayijiang Yisimayi1,2, Weiliang Song1,2, Yanli Xu3, Yunlong Cao1,2 (1. Peking University (China), 2. Changping Laboratory (China), 3. Beijing Ditan Hospital, Capital Medical University (China))
[P087]Analysis of metabolic reprogramming in macrophages utilizing genome-wide CRISPR screening
○Shota Yasukura1, Masanori Yoshinaga1, Michael C Bassik2, Osamu Takeuchi1 (1. Department of Medical Chemistry Graduate School of Medicine, Kyoto University (Japan), 2. Department of Genetics, Bassik Lab, Stanford University School of Medicine, Stanford CA, USA (United States of America))
[P089]Annotation of adaptive immune receptor gene in mammalian genome
○Hao Zhou1, Kazutaka Katoh1, Daron Standley1 (1. Osaka University (Japan))
[P091]Discovery of Small Molecule Immunomodulators Targeting TCR-CD3 Complex
○Aalaa Alrahman Sherif1, Daron M. Standley1 (1. Department of Genome Informatics, Research Institute for Microbial Diseases (RIMD), Osaka University. (Japan))
[P093]K3-SPG-mediated long-term protection against viral infection
○Asuka Joy Tobuse1, Kouji Kobiyama1,2, Jun Tsuchida1, Teppei Hara1, Masamitsu Ayaka3, Daichi Utsumi3, Areej Sakkour1, Yaeko Nakajima-Takagi4, Motohiko Oshima4, Tomoya Hayashi1, Burcu Temizoz1, Hideo Negishi1, Yasuhiro Yasutomi3, Atsushi Iwama4, Ken J Ishii1,2 (1. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan), 2. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo (Japan), 3. Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition (Japan), 4. Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo (Japan))
[P095]γδ T cell-mediated activation of cDC1 orchestrates CD4+ Th1 cell priming in malaria
Yarob Ibraheem1, Ganchimeg Bayarsaikhan1, Maria Lourdes Macalinao2, Kazumi Kimura1, Katsuyuki Yui1,2,3, Taiki Aoshi1, ○Shin-ichi Inoue1 (1. Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University (Japan), 2. School of Tropical Medicine and Global Health, Nagasaki University (Japan), 3. Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine (Japan))
[P097]Crosstalk of TLR and LXR pathways within lung macrophages against influenza A virus infection
○Satoko Arai1, Toru Miyazaki1 (1. The Institute for AIM Medicine (Japan))
[P099]T cell receptor repertoire and transcriptome profiling of CD8+ T cells in the peripheral blood of dengue virus infection during acute, early and late recovery phases
○Eleonor Avenido Cervantes1,2, Akiko Baba3, Jiun-Yu Jian3, Archival M. Cervantes4, Joseph Evangelista Valencia2, Arthur Dessi E Roman4, Katsuyuki Yui1, Mario Antonio L Jiz II2, Shusaku Mizukami3, Kenji Hirayama1 (1. School of Tropical Medicine and Global Health, Nagasaki University (Japan), 2. Immunology Department, Research Institute for Tropical Medicine, Department of Health (Philippines), 3. Institute of Tropical Medicine, Nagasaki University (Japan), 4. Clinical Research Division, Research Institute for Tropical Medicine (Philippines))
[P101]Bacterial sepsis causes more dramatic pathogenetic changes in the Th1 pathway than does viral (COVID-19) sepsis based on mRNA-microRNA integration analysis
○Sayaka Oda1, Arisa Muratsu2, Shinya Onishi2, Jumpei Yoshimura2, Hisatake Matsumoto2, Yuki Togami2, Hiroshi Ito2, Yumi Mitsuyama2, Hiroshi Ogura2, Jun Oda2, Daisuke Okuzaki1 (1. Osaka University immunology frontier Research Center Human Immunology(SingleCell genomics) (Japan), 2. Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka (Japan))
[S05-5 (P103)]SARS-CoV-2 pneumonia was suppressed in Regnase-1 haploinsufficient mice by altering lung-infiltrating neutrophil diversification
○Keiko Yasuda1, Junichi Aoki1, Kotaro Tanaka1, Shintaro Shichinohe2, Chikako Ono3, Alexis Vandenbon4, Daiya Ohara5, Yukiko Muramoto6, Songling Li7, Daisuke Motooka8, Keiji Hirota5, Takeshi Noda6, Daron M. Standley7, Yuzuru Ikehara9, Tokiko Watanabe2, Yoshiharu Matsuura3, Osamu Takeuchi1 (1. Department of Medical Chemistry Graduate School of Medicine, Kyoto University (Japan), 2. Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University (Japan), 3. Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University (Japan), 4. Laboratory of Tissue Homeostasis, Institute for Life and Medical Sciences, Kyoto University (Japan), 5. Laboratory of Integrative Biological Science, Institute for Life and Medical Sciences, Kyoto University (Japan), 6. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), 7. Department of Genome Informatics, Research Institute for Microbial Diseases, Osaka University (Japan), 8. Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University (Japan), 9. Department of Pathology, Graduate School of Medicine, Chiba University (Japan))